DFZ Participaties

Organ Assist is a medical technology company focused on enhancing the organ transplantation process. The company has developed an innovative system that preserves donor organs by supplying them with oxygen and nutrients immediately following a heart attack. This advanced preservation technology aims to improve the quality and viability of organs during extended transport periods. By optimizing the procurement and preservation processes, Organ Assist seeks to increase the number of transplantable organs and improve the overall success rate of organ transplants, allowing for better testing and assessment by medical professionals. This approach addresses critical challenges in organ transplantation, ultimately benefiting both donors and recipients.

Stroke2Prevent B.V. is engaged in the development and distribution of medical devices focused on improving patient outcomes in cardiology. The company's primary product, A-View, addresses the challenges posed by the trachea's interposition during Transoesophageal Echocardiography (TEE). A-View enhances imaging of the thoracic aortic arch, facilitating the detection of atherosclerosis and the diagnosis of aortic diseases, while also enabling monitoring of vascular flow. This device provides critical information that assists physicians in formulating effective treatment strategies. Additionally, Stroke2Prevent has developed a balloon catheter device designed to aid in the prevention of heart strokes. This device is utilized during surgery by being inserted into the trachea of fully anesthetized patients, filled with saline, to help determine the appropriate cardiac operation strategy and improve outcomes in cardiovascular surgeries.

Sigmascreening B.V. is a medical device company based in Amsterdam, Netherlands, specializing in breast cancer screening technologies. Founded in 2010 as a spin-off from the Academic Medical Center Amsterdam, the company is dedicated to developing innovative products to enhance the effectiveness of digital mammography, which is recognized as the standard method for breast cancer detection. Among its offerings is the Sensitive Sigma Paddle, a device designed to measure the mechanical properties of breast tissue during compression, thereby improving screening accuracy. Sigmascreening is committed to advancing the field of breast cancer detection through its research and development initiatives.

Hemics is a medical device company focused on enhancing the quality of life for patients with Rheumatoid Arthritis (RA) through innovative imaging technology. The company develops non-invasive devices that utilize a patented Optical Inflammation Detection technology, which allows for the fast and objective quantification of inflammation. This technology aids rheumatologists in monitoring and assessing disease activity in the joints, particularly in the hands, facilitating more effective treatment strategies. Founded as a spin-out from Royal Philips Electronics, Hemics aims to provide an operator-independent solution that supports rheumatologists in their clinical assessments of inflammatory conditions associated with RA.

Mofixx is improving ergonomics for minimally invasive surgery.

Grendel Games is a game development studio based in The Netherlands that focuses on creating serious games aimed at fostering positive change in society. The studio's work is centered on enhancing physical and mental health, as well as addressing important social issues such as childhood obesity and surgical skills training. By leveraging engaging gameplay, Grendel Games seeks to raise awareness and promote well-being among players globally.

Organ Assist is a medical technology company focused on enhancing the organ transplantation process. The company has developed an innovative system that preserves donor organs by supplying them with oxygen and nutrients immediately following a heart attack. This advanced preservation technology aims to improve the quality and viability of organs during extended transport periods. By optimizing the procurement and preservation processes, Organ Assist seeks to increase the number of transplantable organs and improve the overall success rate of organ transplants, allowing for better testing and assessment by medical professionals. This approach addresses critical challenges in organ transplantation, ultimately benefiting both donors and recipients.